Rare diseases
Investigational molecules
Locations
Long-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
GermanyLong-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy
GermanyStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
GermanyStudy Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer
GermanyStudy of NMD670 tablets to improve muscle strength in adults with TYPE 3 spinal muscular atrophy who can walk
GermanyStudy on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis
GermanyStudy on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units
GermanyStudy on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer
GermanyLong-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients
GermanyStudy of Relatlimab, Nivolumab, and 5-Azacytidine for Acute Myeloid Leukemia in Patients Not Eligible for Intensive Chemotherapy
GermanyStudy on Long-Term Safety and Efficacy of Cebsulfase Alfa for Children with Late Metachromatic Leukodystrophy Receiving Intrathecal Enzyme Replacement
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
